Spruce Biosciences Joins the Russell 3000® Index

Spruce Biosciences was added to the Russell 3000® Index effective today, automatically qualifying it for inclusion in the small-cap Russell 2000® Index as part of the annual reconstitution. Management believes index inclusion will enhance visibility among institutional investors, broaden the shareholder base, and support trading liquidity.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.